| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 05/31/2007 | US20070123568 Therapeutic methods using prostaglandin EP4 agonist components |
| 05/31/2007 | US20070123567 Prophylactic pretreatment with antioxidants |
| 05/31/2007 | US20070123566 Isoflavone derivatives of tectoridin, the preparation thereof and the anti-virus medicines containing the same as an effective constituents |
| 05/31/2007 | US20070123565 Donepezil Hydrochloride Form VI |
| 05/31/2007 | US20070123564 Method for preparing phenyl acetic acid derivatives |
| 05/31/2007 | US20070123563 Selective androgen receptor modulators (SARMs); hormone replacement therapies, bone and metabolic disorders, anticarcinogenic agents |
| 05/31/2007 | US20070123562 Compositions and methods for treating middle-of-the-night insomnia |
| 05/31/2007 | US20070123561 Preparation of 1,7-disubstituted azabensimidazoles as kinase inhibitors |
| 05/31/2007 | US20070123560 Dehalogeno-compounds |
| 05/31/2007 | US20070123559 PACKAGING FOR 1-(2-METHYLPROPYL)-1H-IMIDAZO[4,5-c] QUINOLIN-4-AMINE-CONTAINING FORMULATION |
| 05/31/2007 | US20070123558 Immune response modifier formulations containing oleic acid and methods |
| 05/31/2007 | US20070123557 side effects reduction; treating an obstructive disease of the respiratory tract or for treating overactive bladder; 3-oxa-9-azatricyclo(3.3.1.0(2,4)nonane derivatives |
| 05/31/2007 | US20070123556 Treatment with Sigma Receptor Agonists Post-Stroke |
| 05/31/2007 | US20070123555 Prevention and treatment of hearing disorders |
| 05/31/2007 | US20070123554 Pyrazoloacrydone derivative-containing solution |
| 05/31/2007 | US20070123553 Aryl imidazoles and their use as anti-cancer agents |
| 05/31/2007 | US20070123552 Method of manufacturing of 7-ethyl-10-hydroxycamptotecin |
| 05/31/2007 | US20070123551 Use of metabotropic glutamarate receptor 5 (mglur5) antagonists for the treatment of gastrointestinal disorders |
| 05/31/2007 | US20070123550 t-butyl ester of (+)-7-(4-(4-fluorophenyl)-6-isopropyl-2-(N-methyl-N-methane-sulfonylaminopyrimidin)-5-yl)-3(R)hydroxy-5-oxo-(E)-6-heptenoic acid; crystalline forms may be easier to handle and process than oil intermediates; crystallization in methanol/H2O; heating, cooling, seeding, cooling, recovering |
| 05/31/2007 | US20070123549 platelet activating factor aceylhydrolase inhibitors such as 1-(N-(2-(diethylamino)ethyl)-N-(4-(4-trifluoromethylphenyl)benzyl)aminocarbonylmethyl)-2-(4-fluorobenzyl)thio-5-ethylpyrimidin-4-one; for treatment of atherosclerosis |
| 05/31/2007 | US20070123548 Pth agonists |
| 05/31/2007 | US20070123547 [4-(6-halo-7-substituted-2,4-dioxo-1,4-dihydro-2h-quinazolin-3-yl)-phenyl]-5-chloro-thiophen-2-yl-sulfonylureas and forms and methods related thereto |
| 05/31/2007 | US20070123546 (S)-2-Amino-6-benzyl-7-[4-fluoro-2-(2-fluoro-pyridin-3-yl)-phenyl]-4-methyl-7,8-dihydro-6H-pyrido[4,3-d]pyrimidin-5-one;cellular proliferative, viral, autoimmune, cardiovascular, and central nervous system diseases |
| 05/31/2007 | US20070123545 (1R,4S) or (1S,4R)-1-Amino-4-(hydroxymethyl)-2-cyclopentene D- or L-hydrogen tartrate intermediates |
| 05/31/2007 | US20070123544 Non-nucleotide compositions and method for treating pain |
| 05/31/2007 | US20070123543 Novel compounds |
| 05/31/2007 | US20070123542 Substituted [4-(4-phenyl-piperazin-1-yl)-cyclohexyl]-urea compounds |
| 05/31/2007 | US20070123541 Fungicidal composition comprising a pyridylethylbenzamide derivative and a compound capable of inhibiting the ergosterol biosynthesis |
| 05/31/2007 | US20070123540 Sexual desire enhancing medicaments comprising benzimidazolone derivatives |
| 05/31/2007 | US20070123539 Treatment of Restenosis and Stenosis with Dasatinib |
| 05/31/2007 | US20070123538 Compositions comprising a combination of CCR5 and CXCR4 antagonists |
| 05/31/2007 | US20070123537 Quinazoline derivatives for the treatment of herpesviral infections |
| 05/31/2007 | US20070123536 Treatment of sexual disorders |
| 05/31/2007 | US20070123535 3-Amino-1-arylpropyl azaindoles and uses thereof |
| 05/31/2007 | US20070123534 N-(3-Fluoro-4-(5-methyl-6-(2-(4-methylpiperazin-1-yl)ethoxy)pyrrolo[2,1 -f][1,2,4]triazin-4-yloxy)phenyl)-1-(4-fluorophenyl)-2-oxo-1,2-dihydropyridine-3-carboxamide; inhibit protein tyrosine kinase activity of epithelial growth factor receptors; angiogenesis inhibitor, anticarcinigenic; breast cancer |
| 05/31/2007 | US20070123532 Piperazine derivatives |
| 05/31/2007 | US20070123531 4-Bromo-5-(2-chloro-benzoylamino)-1h-pyrazole-3-carboxylic acid (phenyl) amide derivatives and related compounds as bradykinin b1 receptor antagonists for the treatment of inflammatory diseases |
| 05/31/2007 | US20070123530 e.g. (2-chloropyrimidin-4-yl)-(4-ethyl-3H-thiazol-2ylidene)-acetonitrile,[4-(4-chlorophenyl)-1,3-thiazol-2(3H)-ylidene](2-chloropyrimidin-4-yl)acetonitrile; Jun N-terminal kinase and Glycogen Synthase Kinase 3 inhibitor; antidiabetic, antiinflammatory, anticarcinogenic agent; neurodegenerative diseases |
| 05/31/2007 | US20070123529 Substituted biphenyl compounds |
| 05/31/2007 | US20070123528 Indole-amid derivatives which possess glycogen phosphorylase inhibitory activity |
| 05/31/2007 | US20070123527 3-Amino-1-arylpropyl indoles and aza-substituted indoles and uses thereof |
| 05/31/2007 | US20070123526 (1,1-dioxo-thiomorpholin-4-yl)-[5-(1-isopropyl-piperidin-4-yloxy)-1-(2,2,2-trifluoro-ethyl)-1H-indol-2-yl]-methanone; antagonists or inverse agonists at histamine 3 receptor; antidiabetic agent, antidepressant, neurodegenerative diseases; obesity; dopamine, serotonin and norepinephrine release agent |
| 05/31/2007 | US20070123525 5-Substituted indole-2-carboxamide derivatives |
| 05/31/2007 | US20070123524 Such as N-(2-ethoxybenzyl)-5-hydroxy-1-methyl-2-(4-methylphenyl)-6-oxo-1,6-dihydropyrimidine-4-carboxamide; inhibitors of HIV replication; with other HIV/AIDS antivirals, anti-infectives, immunomodulators, antibiotics or vaccines; AIDS |
| 05/31/2007 | US20070123523 Inhibitors of cathepsin s |
| 05/31/2007 | US20070123522 5-lipoxygenase-activating protein (flap) inhibitors |
| 05/31/2007 | US20070123521 Cinnamoyl derivatives and use thereof |
| 05/31/2007 | US20070123520 Methylene blue therapy of avian influenza |
| 05/31/2007 | US20070123519 Benzo-1,4-diazepin-2-one derivatives as phosphodiesterase pde2 inhibitors, preparation and therapeutic use thereof |
| 05/31/2007 | US20070123518 Product designed to protentiate the therapeutic effects and to enhance the action of medicinal preparations |
| 05/31/2007 | US20070123517 Pharmacological treatment for sleep apnea |
| 05/31/2007 | US20070123516 Method of treating mucus hypersecretion |
| 05/31/2007 | US20070123515 1,5-Substituted indol-2-yl amide derivatives |
| 05/31/2007 | US20070123514 Methods of modulating neurotrophin-mediated activity |
| 05/31/2007 | US20070123513 6-thiomorpholin-4-yl-pyridine-3-sulfonic acid 4-chloro-2-methoxy-benzoylamide; ammonium salt of3-methyl-3,4,5,6-tetrahydro-2H-[1,2']bipyridinyl-5'-sulfonic acid 4-chloro-2-methoxy-benzoylamide; anticarcinogenic agent |
| 05/31/2007 | US20070123512 Propionamide derivatives useful as androgen receptor modulators |
| 05/31/2007 | US20070123511 Benzopyranone compounds, compositions thereof, and methods for treating or preventing cancer |
| 05/31/2007 | US20070123510 Guanidine derivatives |
| 05/31/2007 | US20070123509 Carboxamide derivatives |
| 05/31/2007 | US20070123508 PAR2-modulating compounds and their use |
| 05/31/2007 | US20070123507 Process for converting heterocyclic ketones to amido-substituted heterocycles |
| 05/31/2007 | US20070123506 4-{4-[3-[3-(4-Fluorophenyl)-3-hydroxypropyl]-2-(4-methoxyphenyl)-4-oxoazetidin-1-yl]benzylamino}butane-1-sulfonic acid; antilipemic, antidiabetic and hypoglycemic agents; insulin resistance |
| 05/31/2007 | US20070123505 Heterocycle-substituted 3-alkyl azetidine derivatives |
| 05/31/2007 | US20070123504 2-phenyl-5-trifluoromethyl-oxazole-4-carboxylic acid [6-(ethyl-methyl-amino)-pyridin-3-yl]-amide; obesity, type II diabetes mellitus and metabolic syndrome |
| 05/31/2007 | US20070123503 Cyclic salen-metal compounds: reactive oxygen species scavengers useful as antioxidants in the treatment and prevention of diseases |
| 05/31/2007 | US20070123502 inducing apoptosis in malignant cells selected from breast cancer cells, non-small cell lung cancer cells, myeloma cells and colon tumor cells, comprising administering a platinum (IV) hexachloride complex with 1-[4-(1-hydroxypropyl)piperazin-1-yl]propan-1-ol; STAT proten inhibitors |
| 05/31/2007 | US20070123501 Glutathione peroxidase mimetics and uses thereof |
| 05/31/2007 | US20070123500 Prodrugs of ERbeta-selective substances, processes for their preparation and pharmaceutical compositions comprising these compounds |
| 05/31/2007 | US20070123499 Compositions and methods for treatment and prevention of gastrointestinal disorders |
| 05/31/2007 | US20070123498 Combination of organic compounds |
| 05/31/2007 | US20070123497 For parental administration |
| 05/31/2007 | US20070123496 Use of aminoguanidine or aminoguanidine analogs for the treatment of diseases of the nervous system |
| 05/31/2007 | US20070123495 Pyrrolo-naphthyl acids and methods for using them |
| 05/31/2007 | US20070123494 Pyridopyrazine derivatives and their use |
| 05/31/2007 | US20070123493 Benzamide derivative |
| 05/31/2007 | US20070123492 Analogs of lysophosphatidic acid and methods of making and using thereof |
| 05/31/2007 | US20070123491 Podophyllotoxin derivatives as igf-1r inhibitors |
| 05/31/2007 | US20070123490 Administeringa cellulose derivative; controlling gene expression of stearoyl-coa desaturase o rATPF1;controlling fat metabolism in tissues |
| 05/31/2007 | US20070123489 Administering 2-O desulfated heparin or 2-O, 3-O desulfated heparin; does not produce platelet activation in the presence of serum containing HIT antibodies |
| 05/31/2007 | US20070123488 Pharmaceutical composition comprising a zinc-hyaluronate complex for the treatment of multiple sclerosis |
| 05/31/2007 | US20070123483 Method and composition for treating obesity by targeting cathespin |
| 05/31/2007 | US20070123478 Compositions useful for reducing nephrotoxicity and methods of use thereof |
| 05/31/2007 | US20070123477 Compositions comprising amphotericin B, methods, and systems |
| 05/31/2007 | US20070123475 podophyllotoxin analogs such as 4-beta-[(4''-benzamido)-amino]-4'-demethyl-epipodophyllotoxins and their 4'-ester derivatives used in the chemotherapy for various types of cancer |
| 05/31/2007 | US20070123474 Novel loganin analogues and a process for the preparation thereof |
| 05/31/2007 | US20070123473 Glycosylated steroid derivatives with anti-migratory activity |
| 05/31/2007 | US20070123472 Filtering predictive data |
| 05/31/2007 | US20070123471 For use in cosmetics/improving hair growth; prepared from a process comprising partially or totally esterifying vitamin F (fatty acid) with at least one hydroxy group of glucose |
| 05/31/2007 | US20070123470 Enhancement of growth hormone levels with a dipeptidyl peptidase IV inhibitor and a growth hormone secretagogue |
| 05/31/2007 | US20070123464 Methods and reagents for treating inflammation and fibrosis |
| 05/31/2007 | US20070123461 Reproductive management |
| 05/31/2007 | US20070123459 IL-17 like molecules and uses thereof |
| 05/31/2007 | US20070123452 Method of selecting novel immunosuppressant |
| 05/31/2007 | US20070123451 Use of adiponectin to diagnose and treat malignancy |
| 05/31/2007 | US20070123449 High load particles for inhalation having rapid release properties |
| 05/31/2007 | US20070123448 Novel chemical entities affecting neuroblastoma tumor-initiating cells |
| 05/31/2007 | US20070122866 Protein having PGE2 synthase activity and use thereof |
| 05/31/2007 | US20070122860 Diagnosis and treatment of diseases arising from defects in the tuberous sclerosis pathway |
| 05/31/2007 | US20070122843 Isoflavonoid analogs and their metal complexes as anti-cancer agents |
| 05/31/2007 | US20070122503 Use of extracts from cimicifuga racemosa and of tectorigenin as an estrogen-type, organoselective medicament having no uterotrophic effect |